Artivion | CRY - Ebitda

Stock Price
38.33
Daily Change
0.33 0.87%
Monthly
-13.50%
Yearly
35.63%
Q1 Forecast
37.14

Artivion reported $6.87M in EBITDA for its fiscal quarter ending in March of 2023.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Accuray USD -685K 900K Sep/2024
AngioDynamics USD -369K 2.01M Feb/2025
AtriCure USD 19.86M 2.06M Dec/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Integra LifeSciences USD 78.45M 550.67M Sep/2025
J&J USD 9.52B 389M Sep/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 7.73M 7.64M Sep/2024
Pfizer USD 6.08B 351M Sep/2025
ResMed USD 547.48M 27.46M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Surmodics USD 1.53M 485K Sep/2024
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD 207.62M 15.28M Jun/2025
Terumo JPY 69.99B 3.22B Dec/2025
Trinity Biotech USD -9.6M 7.64M Dec/2024